Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Manag Care Spec Pharm ; 24(8): 769-776, 2018 Aug.
Article in English | MEDLINE | ID: mdl-30058984

ABSTRACT

BACKGROUND: Depression is a common mental condition in U.S. older adults. To improve rates of underdiagnosis and undertreatment for depression and other mental health conditions in primary care settings, the U.S. Preventive Services Task Force (USPSTF) updates and disseminates its depression screening guideline regularly. OBJECTIVE: To examine the effects of the 2009 USPSTF depression screening recommendation on the 3 following outcomes: diagnoses of mental health conditions, antidepressant prescriptions (overall and potentially inappropriate), and provision of nonpharmacological psychiatric services in office-based outpatient primary care visits made by adults aged 65 or older. METHODS: Data from the 2006-2012 National Ambulatory Medical Care Survey (NAMCS), a nationally representative sample of office-based outpatient primary care visits among older adults (n = 15,596 unweighted), were used. NAMCS represents physician practicing patterns of ambulatory medical care services utilization at the national level. Using a series of multivariate difference-in-differences analyses, we estimated effects of the USPSTF depression screening recommendation on the previously mentioned outcomes by comparing pre- (2006-2009) and post- (2010-2012) periods to describe primary care physician practice patterns. RESULTS: Differences in any mental health diagnosis by the depression screening status were -34.7% in the pre-2009 period and -20.2% in the post-2009 period, resulting in a differential effect of -14.4% (95% CI = -28.2, -0.6; P = 0.040). No differential effect was found in other outcomes. CONCLUSIONS: While there are mixed findings about efficacy and effectiveness of depression screening in the existing literature, more population-based observational research is needed to strengthen and support current USPSTF depression screening recommendation statements in the United States. DISCLOSURES: Funding for this study was provided by the National Institute on Aging of the National Institutes of Health (#T32AG019134). The authors declare that they do not have any conflicts of interest. Publicly available data were obtained from the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC). Analyses, interpretation, and conclusions are solely those of the authors and do not necessarily reflect the views of the Division of Health Interview Statistics or NCHS of the CDC.


Subject(s)
Antidepressive Agents/therapeutic use , Depression/diagnosis , Health Care Surveys/statistics & numerical data , Mass Screening/methods , Mental Health/statistics & numerical data , Aged , Aged, 80 and over , Ambulatory Care/statistics & numerical data , Depression/drug therapy , Depression/epidemiology , Drug Prescriptions/statistics & numerical data , Female , Humans , Male , Mass Screening/standards , Mental Health/trends , Practice Guidelines as Topic , Prevalence , Primary Health Care/statistics & numerical data , Program Evaluation , United States/epidemiology
2.
Adm Policy Ment Health ; 45(2): 224-235, 2018 03.
Article in English | MEDLINE | ID: mdl-28730279

ABSTRACT

Using data from 2002 to 2012 National Ambulatory Medical Care Survey, we estimated that the prevalence of overall antidepressant prescriptions increased almost twofold from 5.2% in 2002 to 10.1% in 2012 in office-based outpatient visits made by older adults. In addition, older adults were exposed to the risk of potentially avoidable adverse drug events in approximately one in ten antidepressant-related visits, or 2.2 million visits annually. Amitriptyline and doxepin were the two most frequent disease-independent potentially inappropriate antidepressants. Racial/ethnic minorities, and Medicaid beneficiaries had higher odds of potentially inappropriate antidepressant prescriptions (P < 0.05). Efforts to minimize potentially inappropriate antidepressant prescriptions are needed.


Subject(s)
Antidepressive Agents/therapeutic use , Drug Utilization/statistics & numerical data , Drug Utilization/trends , Inappropriate Prescribing/statistics & numerical data , Medication Errors/statistics & numerical data , Medication Errors/trends , Outpatients/statistics & numerical data , Aged , Aged, 80 and over , Ambulatory Care/statistics & numerical data , Female , Forecasting , Humans , Male , Prevalence , United States
3.
Prev Med ; 100: 101-111, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28414065

ABSTRACT

Existing literature shows mixed findings regarding the efficacy and effectiveness of depression screening, and relatively little is known about the effectiveness of depression screening among older adults in primary care visits in the U.S. This study examines the effects of depression screening on the three following outcomes: mood disorder diagnoses, overall antidepressant prescriptions, and potentially inappropriate antidepressant prescriptions among older adults ages 65 or older in office-based outpatient primary care settings. We used data from 2010-2012 National Ambulatory Medical Care Survey (NAMCS), a nationally representative sample of office-based primary care outpatient visits among older adults (n=9,313 unweighted). We employed an instrumental variable approach to control for selection bias in our repeated cross-sectional population-based study. Injury prevention and stress management were selected as instrumental variables, as they were considered completely exogenous to outcomes of interests using conceptual and statistical criteria. We conducted multivariate bivariate probit (biprobit) regression analyses to investigate the effect of depression screening on each outcome, when controlled for other covariates. We found that depression screening was negatively associated with potentially inappropriate antidepressant prescriptions (ß=-2.17; 95% CI -2.80 to -1.53; p<0.001). However, no significant effect of depression screening on diagnosis of mood disorders and overall antidepressant prescriptions was found. Overall, depression screening had a negative effect on potentially inappropriate antidepressant prescriptions. Primary care physicians and other healthcare providers should actively utilize depression screening to minimize potentially inappropriate antidepressant prescriptions in older adult patients.


Subject(s)
Depression/diagnosis , Mass Screening , Mood Disorders , Primary Health Care , Aged , Aged, 80 and over , Antidepressive Agents/therapeutic use , Cross-Sectional Studies , Female , Health Care Surveys , Humans , Male , Mood Disorders/diagnosis , Mood Disorders/drug therapy
4.
Home Healthc Nurse ; 32(3): 146-52, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24584311

ABSTRACT

Medication regimens can be complicated during the transition from hospital to home for a variety of reasons. The primary purpose of this retrospective study was to measure the impact of integrating a pharmacist into a model of care at a Medicare-certified home healthcare agency for clients recently discharged from the hospital. The secondary purpose was to describe the medication-related problems among clients receiving services from the model of care involving a pharmacist. Integrating a pharmacist within the model of care demonstrated a positive clinical impact on clients.


Subject(s)
Home Care Services , Medication Therapy Management/organization & administration , Pharmacists , Adolescent , Adult , Aged , Female , Humans , Male , Medicare , Middle Aged , Models, Organizational , Retrospective Studies , United States , Workforce
5.
Res Social Adm Pharm ; 6(2): 130-42, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20511112

ABSTRACT

BACKGROUND: The Medicare Prescription Drug Improvement and Modernization Act of 2003 provides outpatient prescription drug coverage for Medicare beneficiaries through private insurers. This coverage is available through 2 primary venues: stand-alone prescription drug plans (PDPs) and integrated managed care (or Medicare Advantage) plans that also provide prescription drug coverage (MA-PDs). OBJECTIVES: The first objective was to describe factors associated with Medicare beneficiaries choosing to enroll in any Medicare part D PDP. The second objective was to describe factors associated with the choice of an MA-PD, given enrollment in the part D program. METHODS: The study used a cross-sectional, survey design. Data were collected from a stratified random sample of 5000 community-dwelling adults, aged 65 years and older in the Center for Medicaid and Medicare Services Region 25. Data were collected by means of a mailed questionnaire. Data analyses included univariate and bivariate descriptive statistics and multivariate probit modeling. RESULTS: The overall adjusted response rate was 50.2% (2309 of 4603). Data from 1490 respondents (32.4% of those attempted) were analyzed in this study. Nearly 75% of sample members elected to enroll in one of the Medicare part D coverage options in 2007, with more than 3 times as many choosing a PDP compared with a MA-PD option (57.2% vs 17.8%). A variety of variables including rurality, plan price, perceived future need for medications, and preferences emerged as important predictors of choosing to enroll in any Medicare part D drug plan, whereas rurality, state of residence, and number of diagnosed medical conditions were associated with the decision to enroll in a MA-PD. CONCLUSIONS: Models of health insurance demand and plan choice applied in this context appear to be modestly effective. Rurality and state of residence were particularly important contributors to both of these decisions, as were a variety of individual characteristics.


Subject(s)
Choice Behavior , Community Pharmacy Services/legislation & jurisprudence , Insurance Coverage/legislation & jurisprudence , Insurance, Pharmaceutical Services/legislation & jurisprudence , Medicare Part C/legislation & jurisprudence , Medicare Part D/legislation & jurisprudence , Prescription Drugs/therapeutic use , Aged , Aged, 80 and over , Centers for Medicare and Medicaid Services, U.S. , Community Pharmacy Services/economics , Cost Control , Cross-Sectional Studies , Drug Costs/legislation & jurisprudence , Drugs, Generic/therapeutic use , Eligibility Determination , Female , Health Care Reform , Health Care Surveys , Health Services Accessibility/economics , Health Services Accessibility/legislation & jurisprudence , Health Services Needs and Demand/economics , Health Services Needs and Demand/legislation & jurisprudence , Health Services Research , Humans , Insurance Coverage/economics , Insurance, Pharmaceutical Services/economics , Male , Medicare Part C/economics , Medicare Part D/economics , Prescription Drugs/economics , Socioeconomic Factors , Surveys and Questionnaires , United States
6.
Res Social Adm Pharm ; 3(1): 47-69, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17350557

ABSTRACT

BACKGROUND: Pharmacists' professional roles have maturated to include provision of information, education, and pharmaceutical care services. These changes have resulted in a focus on collaborative pharmacist-patient professional relationships, in which pharmacists and patients both have roles and responsibilities. OBJECTIVE: The study purpose was to investigate pharmacists' and patients' views of selected pharmacist and patient roles in the pharmacist-patient professional relationship, using principles of role theory. Pharmacist and patient role dimensions studied included (1) "information sharing,"(2) "responsible behavior," and (3) "interpersonal communication." "Creating a patient-centered relationship" and "active communication related to health care" were additional pharmacist and patient role dimensions studied, respectively. METHODS: Data were collected via mailed questionnaires from national random samples of 500 patients aged 18 years and older and 500 pharmacists. Internal consistency reliability was estimated for pharmacist and patient role dimensions using Cronbach's coefficient alpha and bivariate correlation analysis. Student's t test was used to compare pharmacists' and patients' views of role dimensions (alpha level of significance=.05). Descriptive statistics were used to characterize the pharmacist and patient samples. RESULTS: The adjusted response rates for the pharmacist and patient groups were 34.9% (173/496) and 40.8% (196/480), respectively. Pharmacist and patient role dimensions exhibited adequate reliability coefficients. Results showed that pharmacists and patients have similar views regarding pharmacists' "information sharing" roles in the relationship, but for the most part, patients agree less about pharmacists' "responsible behavior," "creating a patient-centered relationship," and "interpersonal communication" roles. Regarding patient roles in the relationship, pharmacists and patients have different views about patients' "information sharing," "responsible behavior," "interpersonal communication," and "active communication related to health care" roles. Results suggest that pharmacists more strongly agree that these are patient roles in the relationship than patients do. CONCLUSIONS: If pharmacists and patients agree on relationship roles, the functionality and outcomes of this relationship will be optimized. Future research is needed to monitor trends in pharmacists' and patients' views of their relationship roles and to develop strategies as needed to ensure that pharmacists and patients are following the same relationship script.


Subject(s)
Communication , Patients , Pharmacists , Professional Role , Professional-Patient Relations , Adolescent , Adult , Aged , Aged, 80 and over , Attitude of Health Personnel , Data Collection , Female , Humans , Male , Middle Aged , Pharmaceutical Services
7.
Res Social Adm Pharm ; 2(4): 458-78, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17161806

ABSTRACT

BACKGROUND: There exists a need to conceptualize and understand the roles that pharmacists serve to help convince others such as patients, prescribers, and payers to value their contributions and to plan for the roles they could serve in the future within the health care system. OBJECTIVE: The purpose of this study was to (1) describe and track differences in pharmacists' and patients' views about the pharmacist's and physician's role in medication risk management and risk assessment in 1995, 1998, 2001, and 2004, and (2) describe associations between selected demographic variables and reported opinions about the pharmacist's role using data from 2004. METHODS: Brushwood's Risk Management/Risk Assessment Framework was used as a conceptual guide for developing 2 risk management and 2 risk assessment scenarios. For each scenario, study participants were asked to select the level of responsibility shared by physicians and pharmacists in addressing the drug therapy problem. Data were collected in 1995, 1998, 2001, and 2004 using random samples of pharmacists and patients as study subjects. Descriptive statistics and logistic regression analysis were used for analyzing the data. RESULTS: The results showed that pharmacists view their role as providing risk management information to patients and may view this role as adding value to patient care above and beyond a level that can be provided by a physician alone. In 2004, pharmacists started to view the risk assessment scenarios as being more their responsibility as well. Patients, on the other hand, consistently viewed their physician as having primary responsibility for their health care in all of the scenarios we studied. CONCLUSIONS: Pharmacists view their role as one that adds unique value to a patient's health through their provision of medication risk management and some types of risk assessment. However, patients do not yet view the pharmacist as the primary provider of either medication risk management or risk assessment information.


Subject(s)
Drug Information Services , Drug-Related Side Effects and Adverse Reactions , Pharmacists , Professional Role , Professional-Patient Relations , Risk Management , Attitude of Health Personnel , Humans , Interdisciplinary Communication , Logistic Models , Physician's Role , Physician-Patient Relations , Risk Assessment , Time Factors , United States
8.
Acad Med ; 79(7): 672-6, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15234918

ABSTRACT

The Minnesota Rural Health School (MRHS), which operated from 1996 to 2003, was the University of Minnesota's first initiative that provided rural, community-based, interdisciplinary health professions education. The newly funded Minnesota Area Health Education Center (AHEC) is now coordinating interprofessional rural clinical education at the Academic Health Center level for the university. The service-learning curricular component is one of the most lasting legacies of the MRHS. This article provides a descriptive summary of the initial 61 service-learning projects completed by students from various health professions who participated in the MRHS and indicates the type of projects that have continuing effects. The seven community site coordinators affiliated with the MRHS completed a survey analyzing service-learning projects performed in their communities. Student interest was predominant in selecting 28% of the 61 projects, community interest was paramount in selecting 10%, and a mixture of both student and community interest contributed to 62% of project selection. Thirty of the projects were designed as single interventions, and the remaining 31 projects have ongoing impact. Students demonstrated interprofessional group synergy and significant creativity in addressing multiple community health care issues and needs, within time constraints of only ten to 12 days in which to develop and implement a service-learning project. Two project examples are described in detail to illustrate the challenges and successes of this type of civic engagement.


Subject(s)
Interprofessional Relations , Learning , Schools, Health Occupations/organization & administration , Academic Medical Centers , Curriculum , Forecasting , Minnesota , Schools, Health Occupations/trends
SELECTION OF CITATIONS
SEARCH DETAIL
...